Related Experiment Videos
Managing HIV. Part 5: Treating secondary outcomes. 5.9 HIV-related cardiovascular disease
1Department of Cardiology, St Vincent's Hospital, Sydney, NSW.
The Medical Journal of Australia
|April 15, 1996
Insights
Heart disease is a common, often silent, condition in people with human immunodeficiency virus (HIV). With better treatments extending HIV survival, more patients may develop symptomatic heart conditions.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Heart disease is frequently observed in individuals with human immunodeficiency virus (HIV).
- Cardiac conditions in HIV patients are often asymptomatic, delaying diagnosis and treatment.
- Advances in antiretroviral therapy have significantly increased the lifespan of people living with HIV.
Purpose of the Study:
- To highlight the growing concern of symptomatic heart disease in the aging HIV-positive population.
- To underscore the need for increased cardiovascular surveillance in HIV patients.
- To anticipate the future burden of cardiac complications in HIV management.
Main Methods:
- This section is not detailed in the provided abstract.
Main Results:
- The abstract does not contain specific results.
Conclusions:
- An increase in symptomatic heart disease among HIV-infected individuals is anticipated.
- Proactive cardiac monitoring is crucial for long-term HIV management.
- Improved HIV therapies necessitate a greater focus on managing comorbidities like heart disease.
Abstract:
Heart disease is common in HIV, but often asymptomatic. As improved therapies prolong the lives of HIV-infected patients, an increase in symptomatic heart disease can be expected.